[
    "{\"step_by_step_thinking\": \"The patient is on treatment with indinavir, zidovudine, lamivudine and ketoconazole. The adverse effects mentioned are nephrolithiasis, hyperlipidemia, central obesity, hyperglycemia and insulin resistance. Looking at the documents, indinavir is associated with nephrolithiasis (Document 0, 3, 5, 16), hyperlipidemia (Document 26), and hyperglycemia leading to insulin resistance (Document 10, 18, 21). Central obesity is a part of lipodystrophy syndrome which is also associated with indinavir (Document 0, 1, 29). Therefore, indinavir is the drug most likely to produce the above adverse effects.\", \"answer_choice\": \"B. Indinavir\"}"
]